Point-of-care biomarkers in asthma management

time to move forward

Kjell Alving (Corresponding Author), Zuzana Diamant, Sarah Lucas, Helgo Magnussen, Ian D Pavord, Giorgio Piancentini, David Price, Nicolas Roche, Joaquin Sastre, Mike Thomas, Omar Usmani, Leif Bjermer, Respiratory Effectiveness Group, Biomarkers Working Group

Research output: Contribution to journalArticle

Abstract

The Global Initiative for Asthma (GINA) report was primarily intended as a strategy document and not a clinical guideline. However, the 2014 update moved the report towards a "practical, clinical practice‐centred document", and has in many countries formed a basis for national guidelines. A possible limitation of the GINA report is its primary focus on evidence coming from randomised controlled trials, potentially leading to the omission of clinically important data coming from real‐life and observational studies, and in conclusions based on highly‐selected asthmatic patients, fulfilling strict study inclusion criteria.
Original languageEnglish
JournalAllergy
Early online date7 Oct 2019
DOIs
Publication statusE-pub ahead of print - 7 Oct 2019

Fingerprint

Point-of-Care Systems
Time Management
Asthma
Biomarkers
Guidelines
Observational Studies
Randomized Controlled Trials

Cite this

Alving, K., Diamant, Z., Lucas, S., Magnussen, H., Pavord, I. D., Piancentini, G., ... Respiratory Effectiveness Group, Biomarkers Working Group (2019). Point-of-care biomarkers in asthma management: time to move forward. Allergy. https://doi.org/10.1111/all.14045

Point-of-care biomarkers in asthma management : time to move forward. / Alving, Kjell (Corresponding Author); Diamant, Zuzana; Lucas, Sarah; Magnussen, Helgo; Pavord, Ian D; Piancentini, Giorgio; Price, David; Roche, Nicolas; Sastre, Joaquin; Thomas, Mike; Usmani, Omar; Bjermer, Leif; Respiratory Effectiveness Group, Biomarkers Working Group.

In: Allergy, 07.10.2019.

Research output: Contribution to journalArticle

Alving, K, Diamant, Z, Lucas, S, Magnussen, H, Pavord, ID, Piancentini, G, Price, D, Roche, N, Sastre, J, Thomas, M, Usmani, O, Bjermer, L & Respiratory Effectiveness Group, Biomarkers Working Group 2019, 'Point-of-care biomarkers in asthma management: time to move forward', Allergy. https://doi.org/10.1111/all.14045
Alving K, Diamant Z, Lucas S, Magnussen H, Pavord ID, Piancentini G et al. Point-of-care biomarkers in asthma management: time to move forward. Allergy. 2019 Oct 7. https://doi.org/10.1111/all.14045
Alving, Kjell ; Diamant, Zuzana ; Lucas, Sarah ; Magnussen, Helgo ; Pavord, Ian D ; Piancentini, Giorgio ; Price, David ; Roche, Nicolas ; Sastre, Joaquin ; Thomas, Mike ; Usmani, Omar ; Bjermer, Leif ; Respiratory Effectiveness Group, Biomarkers Working Group. / Point-of-care biomarkers in asthma management : time to move forward. In: Allergy. 2019.
@article{1607858d0482425fa4a5e17ef93dbf9e,
title = "Point-of-care biomarkers in asthma management: time to move forward",
abstract = "The Global Initiative for Asthma (GINA) report was primarily intended as a strategy document and not a clinical guideline. However, the 2014 update moved the report towards a {"}practical, clinical practice‐centred document{"}, and has in many countries formed a basis for national guidelines. A possible limitation of the GINA report is its primary focus on evidence coming from randomised controlled trials, potentially leading to the omission of clinically important data coming from real‐life and observational studies, and in conclusions based on highly‐selected asthmatic patients, fulfilling strict study inclusion criteria.",
author = "Kjell Alving and Zuzana Diamant and Sarah Lucas and Helgo Magnussen and Pavord, {Ian D} and Giorgio Piancentini and David Price and Nicolas Roche and Joaquin Sastre and Mike Thomas and Omar Usmani and Leif Bjermer and {Respiratory Effectiveness Group, Biomarkers Working Group}",
note = "{\circledC} 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.",
year = "2019",
month = "10",
day = "7",
doi = "10.1111/all.14045",
language = "English",
journal = "Allergy",
issn = "0105-4538",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Point-of-care biomarkers in asthma management

T2 - time to move forward

AU - Alving, Kjell

AU - Diamant, Zuzana

AU - Lucas, Sarah

AU - Magnussen, Helgo

AU - Pavord, Ian D

AU - Piancentini, Giorgio

AU - Price, David

AU - Roche, Nicolas

AU - Sastre, Joaquin

AU - Thomas, Mike

AU - Usmani, Omar

AU - Bjermer, Leif

AU - Respiratory Effectiveness Group, Biomarkers Working Group

N1 - © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

PY - 2019/10/7

Y1 - 2019/10/7

N2 - The Global Initiative for Asthma (GINA) report was primarily intended as a strategy document and not a clinical guideline. However, the 2014 update moved the report towards a "practical, clinical practice‐centred document", and has in many countries formed a basis for national guidelines. A possible limitation of the GINA report is its primary focus on evidence coming from randomised controlled trials, potentially leading to the omission of clinically important data coming from real‐life and observational studies, and in conclusions based on highly‐selected asthmatic patients, fulfilling strict study inclusion criteria.

AB - The Global Initiative for Asthma (GINA) report was primarily intended as a strategy document and not a clinical guideline. However, the 2014 update moved the report towards a "practical, clinical practice‐centred document", and has in many countries formed a basis for national guidelines. A possible limitation of the GINA report is its primary focus on evidence coming from randomised controlled trials, potentially leading to the omission of clinically important data coming from real‐life and observational studies, and in conclusions based on highly‐selected asthmatic patients, fulfilling strict study inclusion criteria.

UR - http://www.mendeley.com/research/pointofcare-biomarkers-asthma-management-time-move-forward

U2 - 10.1111/all.14045

DO - 10.1111/all.14045

M3 - Article

JO - Allergy

JF - Allergy

SN - 0105-4538

ER -